Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2024, Vol. 38 ›› Issue (5): 160-164.doi: 10.6040/j.issn.1673-3770.0.2023.153

• Review • Previous Articles    

Research progress on the role of M receptor signaling pathway in the occurrence and development of myopia

ZHANG Jinmu1, GUO Bin1,2, JIANG Wenjun3, LIU Dongmei4   

  1. 1. College of Ophthalmology and Optometry, Shandong University of Traditional Chinese Medicine, Jinan 250355, Shandong, China2.Postdoctoral Station of Shandong University of Traditional Chinese Medicine, Jinan 250355, Shandong, China3.Shandong Academy of Eye Disease Prevention and Therapy/Shandong Provincial Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Eye Disease, Jinan 250002, Shandong, China4. Department of Cataract, Eye Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Jinan 250002, Shandong, China
  • Published:2024-09-25

PDF (PC)

77

Abstract: M receptors participate in regulating numerous physiological activities in eye tissues. Studies have shown that M receptors can regulate ciliary muscle contraction, regulate the expression of myopia-related neurotransmitters(such as dopamine)and growth factors(such as transforming growth factor β2)in the retina and choroid, and affect scleral fibroblast proliferation and matrix metalloproteinase-2 expression, which in turn affects scleral remodeling and axial growth, ultimately affecting the occurrence and development of myopia. In recent years, a large number of animal experiments and clinical studies have confirmed that M receptor antagonists effectively delay the progression of myopia.This article provides a brief review of the role of the M receptor signaling pathway in the occurrence and development of myopia in different eye tissues(ciliary muscle, retina, choroid, and sclera), to provide ideas for the studing of myopia-related mechanisms and clinical treatment.

Key words: Myopia, M receptor, Ciliary muscle, Retina, Choroid, Sclera

CLC Number: 

  • R778.1+1
[1] 刘凌, 张美霞. 近视的药物治疗[J]. 山东大学耳鼻喉眼学报, 2021, 35(4): 123-128. doi: 10.6040/j.issn.1673-3770.0.2020.313 LIU Ling, ZHANG Meixia. Drug therapy for myopia[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2021, 35(4): 123-128. doi: 10.6040/j.issn.1673-3770.0.2020.313
[2] Mathis U, Feldkaemper M, Wang M, et al. Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken[J]. Albrecht Von Graefes Arch Fur Klin Und Exp Ophthalmol, 2020, 258(2): 319-333. doi:10.1007/s00417-019-04573-y
[3] Chiang ST, Phillips JR. Effect of atropine eye drops on choroidal thinning induced by hyperopic retinal defocus[J]. J Ophthalmol, 2018: 8528315. doi:10.1155/2018/8528315
[4] Yam JC, Jiang YN, Lee J, et al. The association of choroidal thickening by atropine with treatment effects for myopia: two-year clinical trial of the low-concentration atropine for myopia progression(LAMP)study[J]. Am J Ophthalmol, 2022, 237: 130-138. doi:10.1016/j.ajo.2021.12.014
[5] 李佳芹, 毕爱玲, 毕宏生. 睫状肌功能结构异常与近视的关系研究进展[J]. 山东医药, 2023, 63(6): 111-114. doi:10.3969/j.issn.1002-266X.2023.06.027 LI Jiaqin, BI Ailing, BI Hongsheng. Research progress on the relationship between abnormal functional structure of ciliary muscle and myopia[J]. Shandong Medical Journal, 2023, 63(6): 111-114. doi:10.3969/j.issn.1002-266X.2023.06.027
[6] Company V, Moreno-Bravo JA, Perez-Balaguer A, et al. The amniote oculomotor complex[J]. Anat Rec, 2019, 302(3): 446-451. doi:10.1002/ar.23827
[7] Tong LY, Cui DM, Zeng JW. Effects of topical pilocarpine on ocular growth and refractive development in rabbits[J]. Eur J Ophthalmol, 2021, 31(4): 2107-2115. doi:10.1177/1120672120934962
[8] Tran HDM, Tran YH, Tran TD, et al. A review of myopia control with atropine[J]. J Ocul Pharmacol Ther, 2018, 34(5): 374-379. doi:10.1089/jop.2017.0144
[9] Nickla DL, Jordan K, Yang J, et al. Effects of time-of-day on inhibition of lens-induced myopia by quinpirole, pirenzepine and atropine in chicks[J]. Exp Eye Res, 2019, 181: 5-14. doi:10.1016/j.exer.2019.01.008
[10] Yam JC, Li FF, Zhang XJ, et al. Two-year clinical trial of the low-concentration atropine for myopia progression(LAMP)study: phase 2 report[J]. Ophthalmology, 2020, 127(7): 910-919. doi:10.1016/j.ophtha.2019.12.011
[11] Yam JC, Jiang YN, Tang SM, et al. Low-concentration atropine for myopia progression(LAMP)study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control[J]. Ophthalmology, 2019, 126(1): 113-124. doi:10.1016/j.ophtha.2018.05.029
[12] 陈辉. 毒蕈碱拮抗剂减缓近视发展的研究进展[J]. 中华实验眼科杂志, 2017, 35(6): 556-560. doi:10.3760/cma.j.issn.2095-0160.2017.06.015 CHEN Hui. Advances of muscarinic antagonists slowing the progression of myopia[J]. Chinese Journal of Experimental Ophthalmology, 2017, 35(6): 556-560. doi:10.3760/cma.j.issn.2095-0160.2017.06.015
[13] Ruan Y, Patzak A, Pfeiffer N, et al. Muscarinic acetylcholine receptors in the retina-therapeutic implications[J]. Int J Mol Sci, 2021, 22(9): 4989. doi:10.3390/ijms22094989
[14] 张立华, 闫东升, 周翔天, 等. 毒蕈碱1型受体在人视网膜色素上皮细胞表达的研究[J]. 中华眼科杂志, 2006(12): 1109-1112. doi:10.3760/j: issn: 0412-4081.2006.12.011 ZHANG Lihua, YAN Dongsheng, ZHOU Xiangtian, et al. Expression of muscarinic acetylcholine receptor-1 in human retinal pigment epithelium[J]. Chinese Journal of Ophthalmology, 2006(12): 1109-1112. doi:10.3760/j: issn: 0412-4081.2006.12.011
[15] Laspas P, Zhutdieva MB, Brochhausen C, et al. The M1 muscarinic acetylcholine receptor subtype is important for retinal neuron survival in aging mice[J]. Sci Rep, 2019, 9(1): 5222. doi:10.1038/s41598-019-41425-5
[16] Liu AL, Liu YF, Wang G, et al. The role of ipRGCs in ocular growth and myopia development[J]. Sci Adv, 2022, 8(23): eabm9027. doi:10.1126/sciadv.abm9027
[17] Tao Y, Li XL, Sun LY, et al. Effect of green flickering light on myopia development and expression of M1 muscarinic acetylcholine receptor in guinea pigs[J]. Int J Ophthalmol, 2018, 11(11): 1755-1760. doi:10.18240/ijo.2018.11.04
[18] 王玲, 沙芳, 吴建峰, 等. 电针对负透镜诱导型近视豚鼠视网膜M1受体表达的影响[J]. 眼科新进展, 2015, 35(11): 1001-1004. doi:10.13389/j.cnki.rao.2015.0274 WANG Ling, SHA Fang, WU Jianfeng, et al. Effects of electroacupuncture stimulation on levels of retinal acetylcholine receptors M1 in guinea pig model of lens-induced myopia[J]. Recent Advances in Ophthalmology, 2015, 35(11): 1001-1004. doi:10.13389/j.cnki.rao.2015.0274
[19] Carr BJ, Nguyen CT, Stell WK. Alpha2-adrenoceptor agonists inhibit form-deprivation myopia in the chick[J]. Clin Exp Optom, 2019, 102(4): 418-425. doi:10.1111/cxo.12871
[20] Troilo D, Smith EL 3rd, Nickla DL, et al. IMI - report on experimental models of emmetropization and myopia[J]. Invest Ophthalmol Vis Sci, 2019, 60(3): M31-M88. doi:10.1167/iovs.18-25967
[21] Mathis U, Feldkaemper M, Wang M, et al. Studies on retinal mechanisms possibly related to myopia inhibition by atropine in the chicken[J]. Albrecht Von Graefes Arch Fur Klin Und Exp Ophthalmol, 2020, 258(2): 319-333. doi:10.1007/s00417-019-04573-y
[22] Thomson K, Kelly T, Karouta C, et al. Insights into the mechanism by which atropine inhibits myopia: evidence against cholinergic hyperactivity and modulation of dopamine release[J]. Br J Pharmacol, 2021, 178(22): 4501-4517. doi:10.1111/bph.15629
[23] 向小玲, 杨琴, 兰长骏, 等. 多巴胺能与胆碱能通路在近视发生发展中的作用研究进展[J]. 国际眼科杂志, 2022, 22(9): 1500-1503. doi:10.3980/j.issn.1672-5123.2022.9.16 XIANG Xiaoling, YANG Qin, LAN Changjun, et al. Research progress of the dopaminergic and cholinergic signaling pathways in myopia[J]. International Eye Science, 2022, 22(9): 1500-1503. doi:10.3980/j.issn.1672-5123.2022.9.16
[24] Carr BJ, Mihara K, Ramachandran R, et al. Myopia-inhibiting concentrations of muscarinic receptor antagonists block activation of Alpha2A-adrenoceptors in vitro[J]. Invest Ophthalmol Vis Sci, 2018, 59(7): 2778-2791. doi:10.1167/iovs.17-22562
[25] Troilo D, Smith EL 3rd, Nickla DL, et al. IMI- report on experimental models of emmetropization and myopia[J]. Invest Ophthalmol Vis Sci, 2019, 60(3): M31-M88. doi:10.1167/iovs.18-25967
[26] Li T, Zhou XD, Li B, et al. Effect of MT3 on retinal and choroidal TGF-β2 and HAS2 expressions in form deprivation myopia of guinea pig[J]. J Ophthalmol, 2017, 2017: 5028019. doi:10.1155/2017/5028019
[27] Qian LF, Zhao H, Li XX, et al. Pirenzepine inhibits myopia in guinea pig model by regulating the balance of MMP-2 and TIMP-2 expression and increased tyrosine hydroxylase levels[J]. Cell Biochem Biophys, 2015, 71(3): 1373-1378. doi:10.1007/s12013-014-0359-9
[28] Tong LY, Cui DM, Zeng JW. Topical bendazol inhibits experimental myopia progression and decreases the ocular accumulation of HIF-1α protein in young rabbits[J]. Ophthalmic Physiol Opt, 2020, 40(5): 567-576. doi:10.1111/opo.12717
[29] McBrien NA, Jobling AI, Truong HT, et al. Expression of muscarinic receptor subtypes in tree shrew ocular tissues and their regulation during the development of myopia[J]. Mol Vis, 2009, 15: 464-475
[30] 周翔天, 张立华, 吕帆, 等. 毒蕈碱受体Ⅰ型受体在人眼巩膜成纤维细胞中的表达[J]. 中华眼科杂志, 2005, 41(11): 995-999. doi:10.3760/j: issn: 0412-4081.2005.11.009 ZHOU Xiangtian, ZHANG Lihua, Lü Fan, et al. Expression of muscarinic acetylcholine receptor-1 in human scleral fibroblasts[J]. Chinese Journal of Ophthalmology, 2005, 41(11): 995-999. doi:10.3760/j: issn: 0412-4081.2005.11.009
[31] Liu Q, Wu J, Wang XM, et al. Changes in muscarinic acetylcholine receptor expression in form deprivation myopia in guinea pigs[J]. Mol Vis, 2007, 13: 1234-1244
[32] Barathi VA, Kwan JL, Tan QS, et al. Muscarinic cholinergic receptor(M2)plays a crucial role in the development of myopia in mice[J]. Dis Model Mech, 2013, 6(5): 1146-1158. doi:10.1242/dmm.010967
[33] Barathi VA, Beuerman RW. Molecular mechanisms of muscarinic receptors in mouse scleral fibroblasts: prior to and after induction of experimental myopia with atropine treatment[J]. Mol Vis, 2011, 17: 680-692
[34] Zhao F, Zhou QY, Reinach PS, et al. Cause and effect relationship between changes in scleral matrix metallopeptidase-2 expression and myopia development in mice[J]. Am J Pathol, 2018, 188(8): 1754-1767. doi:10.1016/j.ajpath.2018.04.011
[35] Wu PC, Chuang MN, Choi J, et al. Update in myopia and treatment strategy of atropine use in myopia control[J]. Eye, 2019, 33(1): 3-13. doi:10.1038/s41433-018-0139-7
[36] Vishweswaraiah S, Swierkowska J, Ratnamala U, et al. Epigenetically dysregulated genes and pathways implicated in the pathogenesis of non-syndromic high myopia[J]. Sci Rep, 2019, 9(1): 4145. doi:10.1038/s41598-019-40299-x
[1] ZHANG Liyuan, GUO Yingzhuo, CHEN Jiao, WANG Hua, ZHONG Dingjuan. Clinical effect of 650-nm low-level red light in conjunction with orthokeratology in myopia control [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 52-57.
[2] WANG Dongfang, ZHANG Qingyu, SONG Jike, BI Hongsheng. Assessment of reporting quality of randomized controlled trials on acupuncture preventing and controlling with myopia in children and adolescents based on CONSORT and STRICTA [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(5): 66-79.
[3] ZHANG Liyuan, ZHONG Dingjuan, WANG Hua. Advancements in non-surgical management of myopia and choroidal research [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 149-153.
[4] AI Zhaohui, ZHANG Jie. Research progress in the diagnosis and treatment of incontinentia pigmenti-related eye diseases [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 166-174.
[5] BAO Ying, LIU Zhigao, JANG Pengfei, CUI Wenxuan, ZHENG Xiaoxia, YANG Mengyao, SI Mingwei, WANG Yu, WANG Hong. Clinical observation of compacept in the treatment of diabetes mellitus with CRVO-ME high reflex point [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 55-60.
[6] LI Yang, LIU Dong, CAO Wenjie. Meta-analysis of the effect of red-light therapy on spherical equivalent, axial length, and choroidal thickness in myopic children [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 74-81.
[7] LU Song, XIA Yifan, LI Ziye, WEI Jing. Stickler's syndrome in children without retinal detachment:a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 97-101.
[8] HU Yarou, ZHAO Xinyu, WU Zhenquan, FAN Zixin, YU Zhen, LIU Yaling, CHEN Tingyi, ZENG Jian, ZHANG Guoming. Research progress on refractive status and ocular biometrics in preterm births [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 144-150.
[9] WU Lili, QU Yi. Application of optical tomography angiography and artificial intelligence in choroidal neovascularization secondary to pathologic myopia [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 144-149.
[10] DENG Yu, WANG Jianwei, LIU Ziqiang, LI Yuanyuan, HOU Xiaoyu, JIE Chuanhong. Research progress on the preferred retinal locus in patients with central vision loss [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 150-155.
[11] WANG Xinyu, GAO Lifen, LU Hui, SONG Wenqi, YANG Yu. Related retinal manifestations in Parkinson's disease [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 156-162.
[12] LI Shuting, ZHAO Hui, SI Mingwei, CUI Wenxuan, YANG Mengyao, WANG Hong. Central retinal artery occlusion caused by facial filling with hyaluronic acid: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 66-71.
[13] DING Xiaomin, CUI Yan. Advances in severe acute respiratory syndrome coronavirus 2 study about ophthalmology [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 122-127.
[14] LIU Tianwei, ZHAO Bojun. Research progress on retinal vein occlusion in young people [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 128-137.
[15] LIU Jiangchuan, LI Pengwei, GUO Jianqiang, LU Huiqin. Application of optical coherence tomography in idiopathic epiretinal membrane [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(1): 138-142.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd